From: Using second harmonic generation to predict patient outcome in solid tumors
Univariate analysis | Multivariate analysisa | |||||
---|---|---|---|---|---|---|
Variable | HR | 95 % CI | p | HR | 95 % CI | p |
Age | ||||||
41–55 vs 40 years | 0.59 | 0.27–1.32 | 0.203 | 0.80 | 0.35–1.84 | 0.599 |
56–70 vs 40 years | 0.56 | 0.25–1.26 | 0.159 | 0.41 | 0.13–1.34 | 0.140 |
> 70 vs 40 years | 0.46 | 0.15–1.36 | 0.159 | 0.32 | 0.08–1.27 | 0.105 |
Menopausal status | ||||||
Post-vs premenopausal | 0.98 | 0.55–1.73 | 0.938 | 2.46 | 0.89–6.84 | 0.083 |
Tumor size | ||||||
2–5 vs ≤2 cm | 1.76 | 0.98–3.14 | 0.056 | 0.85 | 0.43–1.70 | 0.650 |
> 5 vs <2 cm | 1.51 | 0.36–6.38 | 0.579 | 0.50 | 0.10–2.42 | 0.386 |
Tumor grade | ||||||
II vs I | 3.15 | 1.30–7.61 | 0.011 | 2.76 | 1.10–6.92 | 0.030 |
III vs I | 4.38 | 1.68–11.45 | 0.003 | 3.38 | 1.15–9.93 | 0.027 |
PgR status | ||||||
Positive vs negative | 0.71 | 0.38–1.35 | 0.297 | 0.61 | 0.30–1.24 | 0.170 |
HER2 status | ||||||
Positive vs negative | 4.06 | 1.71–9.65 | 0.002 | 3.67 | 1.10–6.92 | 0.009 |
Log of F/B ratio | 0.23 | 0.08–0.65 | 0.005 | 0.16 | 0.05–0.55 | 0.004 |